During the past decade, INOVA conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "INOVA" #1 sponsor was "Acessa Health, Inc." with 1 trials, followed by "Bellerophon Pulse Technologies" with 1 trials sponsored, "Denver Health and Hospital Authority" with 1 trials sponsored, "Medtronic Cardiac Surgery" with 1 trials sponsored and "Weill Medical College of Cornell University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "INOVA" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "University of Chicago" with 1 trials as a collaborator, "University of Pittsburgh" with 1 trials as a collaborator and "University of Washington" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "INOVA" are "Appendicitis" (1 trials), "COVID-19" (1 trials), "Coronavirus" (1 trials), "Coronavirus Infection" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "INOVA" in a lesser frequency.

Most popular intervention types in "INOVA" are "Other" (2 trials), "Combination Product" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abdominal or Laparoscopic Myomectomy" (1 trials), "Antimicrobial therapy: Co-trimoxazole or Doxycycline" (1 trials), "Global Fibroid Ablation (GFA)" (1 trials), "INOpulse" (1 trials) and "Liberal Duration of SOC Antibiotic Use" (1 trials). Other intervention names were less common.

The vast majority of trials in "INOVA" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "INOVA". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in INOVA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in INOVA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".